Pharmacopsychiatry 2013; 46(01): 39-40
DOI: 10.1055/s-0032-1321906
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Aseptic Gingivitis Related to Quetiapine Hemifumarate

M. Gahr
1   Department of Psychiatry and Psychotherapy III, University Hospital of Ulm, Ulm, Germany
,
M. A. Kölle
1   Department of Psychiatry and Psychotherapy III, University Hospital of Ulm, Ulm, Germany
,
R. W. Freudenmann
1   Department of Psychiatry and Psychotherapy III, University Hospital of Ulm, Ulm, Germany
,
C. Schönfeldt-Lecuona
1   Department of Psychiatry and Psychotherapy III, University Hospital of Ulm, Ulm, Germany
› Author Affiliations
Further Information

Publication History

received 18 May 2012
revised 08 July 2012

accepted 11 July 2012

Publication Date:
22 August 2012 (online)

Preview

Abstract

Quetiapine hemifumarate (QF) is widely used in psychiatry and is associated with regularly occurring side effects such as dizziness and metabolic problems. Apart from these typical adverse events the agent has attracted attention for several rare phenomena (priapism, cholestasis, rhabdomyolysis) that indeed feature anecdotal character, but are nevertheless indispensable for a comprehensive understanding of the factual risk profile of quetiapine. We present the first report of aseptic gingivitis associated with QF in a patient with mental retardation.